SofWave Medical Ltd. (SOFWF)
OTC Markets OTCPK · USD · Healthcare · Medical Devices
$9.93 (+0.00%) as of
Key statistics
- Market cap
- 361.39M
- P/E (TTM)
- 47.29
- EPS (TTM)
- 0.21
- Dividend yield
- 0.00%
- 52-week range
- 7.00 – 16.25
- Beta
- 0.71
- Revenue (TTM)
- 104.34M
- Profit margin
- 8.48%
- Volume
- 200.00
About SofWave Medical Ltd.
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Yokneam Illit, Israel
- Employees
- 151
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.